Methyl 3-[2,5-bis(trifluoromethyl)phenyl]-9-(4-fluorophenyl)-1-oxaspiro[4.4]non-3-ene-8-carboxylate
C24H19F7O3 — CID 54144926
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 3-[2,5-bis(trifluoromethyl)phenyl]-9-(4-fluorophenyl)-1-oxaspiro[4.4]non-3-ene-8-carboxylate
Methyl 3-[2,5-bis(trifluoromethyl)phenyl]-9-(4-fluorophenyl)-1-oxaspiro[4.4]non-3-ene-8-carboxylate (PubChem CID 54144926) has the molecular formula C24H19F7O3 and a molecular weight of 488.40 g/mol. Its IUPAC name is methyl 3-[2,5-bis(trifluoromethyl)phenyl]-9-(4-fluorophenyl)-1-oxaspiro[4.4]non-3-ene-8-carboxylate.
Molecular Properties
| Compound Name | Methyl 3-[2,5-bis(trifluoromethyl)phenyl]-9-(4-fluorophenyl)-1-oxaspiro[4.4]non-3-ene-8-carboxylate |
|---|---|
| PubChem CID | 54144926 |
| Molecular Formula | C24H19F7O3 |
| Molecular Weight | 488.40 g/mol |
| Exact Mass | 488.12 |
| IUPAC Name | methyl 3-[2,5-bis(trifluoromethyl)phenyl]-9-(4-fluorophenyl)-1-oxaspiro[4.4]non-3-ene-8-carboxylate |
| SMILES | COC(=O)C1CCC2(C=C(c3cc(C(F)(F)F)ccc3C(F)(F)F)CO2)C1c1ccc(F)cc1 |
| InChI | InChI=1S/C24H19F7O3/c1-33-21(32)17-8-9-22(20(17)13-2-5-16(25)6-3-13)11-14(12-34-22)18-10-15(23(26,27)28)4-7-19(18)24(29,30)31/h2-7,10-11,17,20H,8-9,12H2,1H3 |
| InChIKey | ODRNSKOCXLXRBL-UHFFFAOYSA-N |
| XLogP | 6.38 |
| TPSA | 35.53 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 488.40 |
| LogP ≤ 5 | 6.38 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 54144926 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.